Core Insights - Supramolecular technology is gaining significant attention in the cosmetics industry, focusing on "molecular structure" and "intelligent delivery" to enhance ingredient efficacy and stability [3][4][19] - Major international brands like L'Oréal and Shiseido, as well as local companies, are actively developing and applying supramolecular technology in their products [6][9][21] - The technology aims to address traditional active ingredient challenges, such as penetration, stability, and synergy, providing a new pathway for innovation in skincare [20][34] Industry Trends - The emergence of supramolecular technology reflects a broader trend in the cosmetics industry towards more effective, gentle, and intelligent products, driven by consumer demand for enhanced efficacy [19][20] - Companies are exploring various supramolecular pathways, including microcapsules, co-crystals, and self-assembly techniques, indicating a diverse approach to ingredient application [4][9] - The technology is seen as a response to the industry's need for differentiation and innovation, with brands focusing on structural optimization to enhance product performance [12][34] Product Development - L'Oréal's fourth-generation collagen cream and Shiseido's new products utilize supramolecular technology to improve ingredient absorption and efficacy [7][8] - Local brands like Fulejia and Marubi are also leveraging supramolecular techniques to enhance their product offerings, demonstrating the technology's widespread adoption [9][10] - The collaboration between companies and research institutions is crucial for advancing supramolecular technology, as seen in partnerships like that of Fulejia and Shenzhen Shanhai Innovation Technology [21][23] Scientific Foundation - Supramolecular technology is based on supramolecular chemistry, which studies the interactions between molecules through non-covalent bonds, allowing for dynamic and reversible assembly [14][15] - This approach differs fundamentally from traditional molecular modification, offering a modular and flexible method for creating complex structures [16][19] - The technology's potential for precise and intelligent delivery of active ingredients is being explored across various applications in the cosmetics sector [24][34] Challenges and Future Outlook - The industry faces challenges in establishing the stability and efficacy of supramolecular formulations in complex systems, which requires rigorous quality control and production processes [28][30] - Effective consumer education on supramolecular technology is essential, as understanding its benefits and applications can enhance market acceptance [30][32] - The future of supramolecular technology in cosmetics is promising, with potential applications extending beyond skincare to areas like hair care and fragrance, indicating a broad scope for innovation [35][36]

Core Viewpoint - Procter & Gamble (P&G) is shifting its growth strategy from external acquisitions to internal development, with a focus on the Chinese market and artificial intelligence (AI) as key pillars for future growth [6][18][23]. Group 1: Leadership Transition - Jon Moeller will officially hand over the CEO position to Shailesh Jejurikar on January 1, 2026, marking the fifth CEO change in two decades for P&G [6][8]. - The leadership transition occurs at a time when the company is re-evaluating its growth strategies amid a challenging consumer environment [6][16]. Group 2: Strategic Focus - P&G's CFO, Andre Schulten, emphasized that the company is confident in its growth trajectory, particularly in the unique Chinese market, despite facing challenges such as consumer confidence and retail structural changes [6][8]. - The company has undergone a significant market restructuring in China, described as a "complete self-revolution," which includes redefining its business model and optimizing its distribution network [7][8]. Group 3: Financial Performance - P&G's net sales increased from $76.1 billion in fiscal year 2021 to $84.3 billion in fiscal year 2025, marking five consecutive years of growth [8][9]. - Organic sales in the Chinese market grew by 5% year-over-year, with a positive trend observed over multiple quarters [8][9]. Group 4: Brand Management and Innovation - Approximately 60% of P&G's net sales in China are now classified as "excellent," indicating significant room for improvement in the remaining 40% [10]. - P&G has launched several innovative products in China, such as the new SK-II and Olay lines, which have seen substantial online growth [12][14]. Group 5: AI and Digital Transformation - P&G is implementing a "Supply Chain 3.0" initiative aimed at achieving fully automated manufacturing operations, with AI playing a crucial role in this transformation [18][19]. - The company is also focusing on integrating AI across various functions, including logistics, demand forecasting, and product development, to enhance operational efficiency [19][20]. Group 6: Future Growth Strategy - P&G's growth strategy is evolving to rely less on large-scale acquisitions and more on optimizing its existing portfolio and improving operational efficiency [23][26]. - The ongoing restructuring plan initiated in June 2023 aims to redefine growth sources and enhance capabilities across investment portfolio optimization, supply chain improvements, and organizational design [26][28].

Core Viewpoint - The article emphasizes the importance of integrating clinical insights into the skincare industry, highlighting the release of the "2025 China Medical Skincare Clinical Insight Report" as a pivotal moment for bridging the gap between clinical practice and product development [2][3][4]. Summary by Sections Insight Report Overview - The "2025 China Medical Skincare Clinical Insight Report" was launched at the SIA2025 Scientific Skincare Innovation Alliance Annual Conference, marking a significant shift in understanding how dermatologists utilize efficacy skincare products in clinical settings [2][3]. - This report serves as a comprehensive guide for the skincare industry, aiming to eliminate the information barrier between clinical medicine and industry [4]. Methodology and Findings - The report is based on extensive research involving 11,253 dermatologists and 25 industry experts, focusing on five core skin conditions: acne, atopic dermatitis, pigmentary disorders, sensitive skin, and perioperative care in aesthetic medicine [6][8]. - It outlines a full-cycle management approach for skin issues, providing practical guidelines validated by clinical experience [6][14]. Clinical Pathways and Recommendations - The report details specific intervention points for efficacy skincare products throughout the management process of various skin conditions, emphasizing the importance of barrier repair and maintenance in treatment plans [14][15]. - It highlights the necessity of a comprehensive skincare strategy during aesthetic procedures, with 91% of dermatologists recommending a holistic skincare approach [17][19]. Bridging Clinical and Industry Practices - The report translates complex clinical language into actionable insights for product development, addressing the disconnect between medical professionals and the skincare industry [20][21]. - It identifies the role of dermatologists as natural judges of product safety and efficacy, providing a foundation for evidence-based product development [21][22]. Future Opportunities - The report positions dermatologists as key players in the future of skin health management, revealing untapped market potential in the aesthetic medicine sector [23]. - It emphasizes the need for a collaborative approach between clinical insights and product innovation to meet the evolving demands of consumers [24][26].

Core Viewpoint - The article discusses the establishment of Shangcheng (Shanghai) Enterprise Development Co., Ltd., which aims to create a "smart manufacturing ecosystem" for daily chemical products, aligning with the theme of the 2025 Oriental Beauty Valley International Cosmetics Conference, "Moving Towards New, Beauty Coexists" [2][6][20]. Company Overview - Shangcheng was founded in 2024, with Shanghai Chengxing Machinery Electronics Co., Ltd. holding 60% and Guangzhou Tashan Zhiyu Industrial Holdings Co., Ltd. holding 40% [6]. - The company focuses on four core areas: research and development of daily chemical equipment, cosmetics production and sales, brand operation management, and software services, aiming to create an integrated ecosystem [6][11]. Industry Context - The 2025 Oriental Beauty Valley International Cosmetics Conference highlighted the importance of industry collaboration for high-quality development in the cosmetics sector [6]. - The establishment of Shangcheng reflects a response to unmet needs in the industry, particularly in addressing the challenges brands face when considering self-built factories [4][11]. Business Model - Shangcheng's business model is centered on building a "smart manufacturing ecosystem" that provides comprehensive solutions, including brand incubation, production, team training, warehousing, logistics, and information support [11][12]. - The company offers three differentiated service models: 1. "Shared Production Base" allows brands to operate in Shangcheng's facilities before investing in their own factories [11]. 2. "Capacity Elastic Support" provides temporary production resources to brands facing short-term order peaks [12]. 3. Comprehensive support services reduce coordination costs for clients [12]. Project Development - The "Smart Manufacturing Base for Daily Chemical Equipment" project was launched in November 2025, with a total investment of 240 million yuan and covering an area of 35 acres [12][14]. - The base will include five core areas: smart manufacturing center, R&D innovation platform, information service platform, brand operation and marketing center, and talent training center [14]. Growth Expectations - Shangcheng anticipates an average annual growth rate of around 15% over the next three years, leveraging the existing customer base and reputation of its parent company, Chengxing [19]. - The company aims to convert traditional equipment clients into users of its comprehensive service ecosystem while expanding into new OEM and brand operation businesses [19]. Challenges and Market Dynamics - The company faces significant competition in the market, with a need for differentiation due to the high level of service homogeneity and oversupply [19]. - The success of Shangcheng's ecosystem model will depend on its ability to integrate into the broader regional industrial ecosystem and collaborate with various stakeholders in the Oriental Beauty Valley [20].

Core Viewpoint - The PDRN skincare market is experiencing rapid growth, prompting the industry to consider its future direction and potential applications more thoughtfully [2][4][28]. Group 1: Market Position and Growth - Zhanmiya has been recognized as the leading brand in China's PDRN skincare market, receiving certification from Frost & Sullivan for having the highest sales in this segment [6][7]. - The market for PDRN products is projected to reach $289 million by 2025, with a significant increase in the number of registered PDRN products from over 1,700 in 2022 to 17,000 in the first half of this year [28][30]. - Zhanmiya's products have shown strong performance in both online and offline channels, achieving high order and repurchase rates, particularly during major sales events like Double Eleven [7][8]. Group 2: Product Innovation and Technology - Zhanmiya has developed proprietary technologies such as "球PDRN™" to enhance the transdermal absorption of PDRN, addressing previous technical challenges in the application of this ingredient [8][12]. - The newly launched 球PDRN™超能水光面膜 incorporates patented components that target mitochondrial repair and collagen synthesis, demonstrating significant efficacy in improving skin hydration and reducing signs of aging [17][19]. - The product's performance metrics include a 197.62% increase in ATP production efficiency and a 31.35% increase in type I collagen expression, showcasing its advanced formulation [17][19]. Group 3: Industry Standards and Compliance - The lack of standardized regulations in the PDRN skincare sector has raised concerns about product efficacy and safety, highlighting the need for clear guidelines [30][34]. - Zhanmiya and its parent company, Baihong Group, are actively involved in establishing industry standards, including the recently released guidelines for PDRN raw material testing [31][33]. - The establishment of these standards aims to ensure high-quality applications of PDRN, providing a framework for brands to measure effectiveness and maintain compliance, thus fostering a healthier market environment [34][35].

Core Viewpoint - The article highlights the dangers of a viral weight loss injection that nearly caused a woman's death, revealing a black market for such products that misuses cosmetic regulations and poses serious health risks [3][4][5]. Group 1: Product Safety and Compliance Issues - The weight loss injection, costing around 900 yuan for a treatment of three injections, was found to have severe side effects, including vomiting and potential cardiac arrest [5][10]. - Many similar products, marketed under names like "Four Point Slimming King" and "Black Gold Transport Protein," have been sold online, with prices ranging from tens to hundreds of yuan, claiming rapid weight loss effects [7][10]. - The products often lack proper labeling and compliance, with some packaging showing only a counterfeit anti-counterfeiting mark and no Chinese labels [12][13]. Group 2: Regulatory Violations and Legal Consequences - The article discusses how these products are often labeled as cosmetic but contain prescription drug ingredients like Semaglutide, which is strictly regulated and should only be used under medical supervision [16][18]. - Investigations revealed that the production of these injections involved illegal procurement of raw materials and misleading labeling, leading to significant legal repercussions for those involved [19][24]. - The article emphasizes that cosmetic products are not permitted for injection, and only medical devices or drugs can be used for such purposes, highlighting the serious legal implications of mislabeling [23][24]. Group 3: Industry Implications and Warnings - The exposure of this black market for weight loss injections serves as a warning for beauty companies attempting to cross into medical aesthetics, stressing the importance of compliance with regulatory standards [21][26]. - Companies are urged to establish robust compliance mechanisms and professional capabilities if they wish to enter the medical device market, as the regulatory requirements are significantly higher than for cosmetic products [25][26]. - The article concludes that the beauty industry must prioritize compliance and professional integrity to avoid legal issues and maintain consumer trust [26].

当美妆行业从"概念营销"迈向"科学实证"，"医研共创"早已不是新鲜口号，而是驱动品牌升级 的核心引擎。 " 作为亚太化妆品科技领域的核心交流平台，SIA科盟大会始终以推动产业从'概念驱动'向'科 学实证'升级为使命，而'医研共创'正是当前美妆品牌突破瓶颈、解决用户真实痛点的关键路 径。 "在SIA科盟未来1 0 0未来皮肤科学大会的开幕式上，中国香妆协会产业研究中心姚永斌 主任的发言精准点出了行业发展的核心趋势。 11月2 7 - 2 9日，被誉为亚太地区化妆品科技领域"风向标"的年度盛会——SIA科盟2 0 2 5会议在 上海隆重举行。本届大会以"美力跨界·专业无界"为主题，汇集了来自全球的顶尖科研机构、 皮肤学专家、临床医生及行业领军品牌，共同探索中国皮肤健康产业的创新路径与科学标准重 建。 值得关注的是，本届大会重磅发布了《2 0 2 5中国医学护肤临床洞察报告》白皮书，从多维度 解析了中国消费者皮肤问题的最新趋势与临床解决方案。同时公布的2 0 2 5年SIA1 0 0年度科学 产品与技术成果，则集中展示了行业在活性成分、功效评价等领域的技术突破。通过多元议题 的深度碰撞与权威成果的集中发布，本届大会 ...

1 2月1日发布的《牙膏分类目录（征求意见稿）》（以下简称《意见稿》），正是在这一背景下出现，将牙膏正式纳入化妆品监管体系的"精 细化层级"。 在 《美妆品牌合规指引》主理人胡滨 看来，这一目录参考化妆品的"四梁八柱"体系，意义在于补齐监管链条，使牙膏从此前的"模糊参照"进 入"明确规则"阶段。他指出：" 监管逻辑并没有变，《意见稿》属于规范性文件，和此前《化妆品分类规则和分类目录》 解决的问题是一样 的，就是把牙膏功效规范化、法治化和科学化，做到有法可依、有科学判断依据。 " 这意味着牙膏被真正拉入了《化妆品监督管理条例》《牙膏监督管理办法》之下的执行层，进入以科学依据和规范用语为基础的监管轨道。 那么，《意见稿》究竟将牙膏功效分为哪几类，解决了什么问题，对牙膏市场未来有何深远影响，企业又该如何反应和动作？ 目录对功效体系的重构，是这次新规最核心的内容。 | 编码 | 功效类别 | 功效机理 | 功效宣称用语 | | --- | --- | --- | --- | | 01 | 基础清洁类 | 辅助牙刷或者牙间隙刷,通过摩擦有助 于达到清洁牙面的软垢和食物残渣,通过 | 清洁牙齿、清洁/洁净口腔、保持口腔卫 ...

线上经济流量时代，造就了太多"爆品"的品牌神话，一度让人们认为，爆发式增长是品牌的常 态。但在线下渠道中，一盘高质量、可持续的慢生意，也许才是美妆经营的本质。 在SIA2 0 2 5科学护肤创新联盟大会上，一个根植于线下渠道的品牌——仙瑟，引起了人们的广 泛关注。只因在以功效叙事获取线上流量为主流生意模型的时代，仙瑟却用医研共创的专业产 品和服务，为线下渠道的增长给出一个值得借鉴的答案。 据《FBe a u t y未来迹》了解，在当下普遍承压的大环境下，通过"医院+医美机构"双轨制，仙 瑟品牌一直保持高速增长，且不断为线下渠道带来增量，引领合作的线下门店走向新的增长曲 线。 仙瑟荣登"未来100皮肤健康未来百强企业榜单" " 我们希望在科盟的助力下，对皮肤医学，对医研共创有更好的前沿性的学习，我们尊重每一 个学者，尊重他们在学术领域的付出，他们让企业的研发有了新的方向，让美妆企业有了更强 的创新力。 " 在创新联盟大会上，仙瑟品牌创始人薛永红在央视网的采访中展示了医研共创专业品牌的底层 研发模型。 仙瑟品牌创始人薛永红接受央视网采访 " 我们会根据消费者的真实需求做研发。 "在薛永红看来，" 过去品牌依据原料 ...

Core Viewpoint - The beauty live-streaming industry is undergoing a significant trust crisis, with issues related to product quality and exaggerated claims becoming increasingly prominent, leading to a need for rebuilding consumer trust [5][20][21] Group 1: Industry Challenges - Recent controversies involving beauty influencers, such as Huamei pausing beauty content updates and Zhu Guagua facing backlash over product quality, highlight the industry's struggles [3][5] - The beauty live-streaming sector is entering a deep adjustment period, marked by a decline in consumer trust and increasing scrutiny over product claims [5][20] - Zhu Guagua's promotion of Maystar shampoo has led to numerous consumer complaints regarding its effectiveness, with users reporting issues like scalp irritation and oiliness [7][9] Group 2: Consumer Concerns - Consumers have raised two main concerns: the poor quality of products and the potential exaggeration of product efficacy claims, revealing flaws in the influencer's product selection process [10][11] - There is a growing skepticism towards influencers' narratives, particularly when discrepancies arise between their claims and the actual product information [10][11] - The backlash against Zhu Guagua's promotional tactics reflects a broader consumer fatigue with scripted and exaggerated marketing strategies [12][20] Group 3: Market Dynamics - The beauty live-streaming market has seen a significant increase in scale, growing from 19.64 billion to 491.68 billion from 2017 to 2023, but the growth rate has slowed to 8.31% last year [18] - The competitive landscape is shifting, with major brands like Han Shu and Estée Lauder increasing their self-broadcasting efforts, thereby squeezing the space for individual influencers [14][22] - New influencers continue to emerge, indicating opportunities for differentiation in a crowded market, but many struggle to maintain consistent rankings in sales [13][14] Group 4: Future Trends - The industry is moving towards a phase where professional expertise and transparent communication will be more valued than emotional manipulation and scripted narratives [21][22] - Innovative approaches, such as emphasizing scientific skincare and transparent pricing, are being adopted to enhance consumer trust and engagement [22][23] - The need for a more rigorous and systematic product selection process, along with clear communication of product efficacy, is becoming essential for influencers to maintain credibility [23]